TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients

scientific article published on October 2004

TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1399-0039.2004.00304.X
P698PubMed publication ID15361124

P2093author name stringFernández-Mestre MT
Gendzekhadze K
Layrisse Z
Rivas-Vetencourt P
P2860cites workCytokine cascade in dengue hemorrhagic fever: implications for pathogenesisQ33949186
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activationQ36082965
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasisQ36365433
Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South AmericaQ39240429
Cytokine gene expression and protein production in peripheral blood mononuclear cells of children with acute dengue virus infectionsQ40585791
Elevated plasma interleukin-10 levels in acute dengue correlate with disease severityQ40632182
Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK.Q46836880
P433issue4
P921main subjectdengue feverQ30953
Dengue virusQ476209
risk factorQ1475848
P304page(s)469-472
P577publication date2004-10-01
P1433published inTissue AntigensQ1573131
P1476titleTNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients
P478volume64

Reverse relations

cites work (P2860)
Q28483765A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice
Q28473775A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice
Q34412344A variant in the CD209 promoter is associated with severity of dengue disease
Q27468820Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-α production by mononuclear phagocytes
Q35727211Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection
Q40230111Apoptotic mediators in patients with severe and non-severe dengue from Brazil
Q36131935Association of FcγRIIa Polymorphism with Clinical Outcome of Dengue Infection: First Insight from Pakistan
Q40258540Association of HLA-DRB1 and TNF genotypes with dengue hemorrhagic fever
Q57292005Association of tumour necrosis factor-α (TNF-α) gene polymorphisms (-308 G>A and -238 G>A) and the risk of severe dengue: A meta-analysis and trial sequential analysis
Q42991886Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis
Q27480369Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced Hemorrhage
Q33402211Changes in hematological and serum biochemical parameters in common marmosets (Callithrix jacchus) after inoculation with dengue virus
Q92257420Characterization of Biomarker Levels in Crimean-Congo Hemorrhagic Fever and Hantavirus Fever with Renal Syndrome
Q27490805Clinical Findings and Pro-Inflammatory Cytokines in Dengue Patients in Western India: A Facility-Based Study
Q35864402Comparative evaluation of permissiveness to dengue virus serotype 2 infection in primary rodent macrophages
Q37540534Complement factor H gene (CFH) polymorphisms C-257T, G257A and haplotypes are associated with protection against severe dengue phenotype, possible related with high CFH expression
Q28974151Cyclooxygenase‐2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents
Q36432712Dendritic cell apoptosis and the pathogenesis of dengue
Q42361145Dengue Virus Induces NK Cell Activation through TRAIL Expression during Infection.
Q35833914Dengue Virus Infection Causes the Activation of Distinct NF-κB Pathways for Inducible Nitric Oxide Synthase and TNF-α Expression in RAW264.7 Cells
Q42996339Dengue infection.
Q28278881Dengue virus life cycle: viral and host factors modulating infectivity
Q24645380Dengue virus pathogenesis: an integrated view
Q27477724Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction
Q34125057Dengue.
Q28298464Dengue: a continuing global threat
Q34785824Elevated dengue virus nonstructural protein 1 serum levels and altered toll-like receptor 4 expression, nitric oxide, and tumor necrosis factor alpha production in dengue hemorrhagic Fever patients.
Q33959381Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections
Q27487400Enhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage Development
Q27490377Gene Expression Profiling during Early Acute Febrile Stage of Dengue Infection Can Predict the Disease Outcome
Q61795471Genetic Determinants of the Re-Emergence of Arboviral Diseases
Q38095237Genetic Susceptibility to West Nile Virus and Dengue
Q40152182High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of Dengue
Q33623859High producer haplotype (CAG) of -863C/A, -308G/A and -238G/A polymorphisms in the promoter region of TNF-α gene associate with enhanced apoptosis of lymphocytes in HIV-1 subtype C infected individuals from North India
Q33419779High producing tumor necrosis factor alpha gene alleles in protection against severe manifestations of dengue
Q59353530Host genetic control of mosquito-borne Flavivirus infections
Q38002407Host genetic susceptibility to severe dengue infection
Q40042448IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever
Q55452170Identification of genetic variants associated with dengue or West Nile virus disease: a systematic review and meta-analysis.
Q33924674Immune correlates for dengue vaccine development
Q40380663Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue
Q40307795Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement.
Q35146621Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes
Q39041179Meta-Analysis of the Relationship between TNF-α (-308G/A) and IL-10 (-819C/T) Gene Polymorphisms and Susceptibility to Dengue
Q50255448Plasma leakage in dengue haemorrhagic fever
Q40122055Polymorphisms of Transporter Associated with Antigen Presentation, Tumor Necrosis Factor-α and Interleukin-10 and their Implications for Protection and Susceptibility to Severe Forms of Dengue Fever in Patients in Sri Lanka
Q36720238Primary dengue virus infections induce differential cytokine production in Mexican patients.
Q29619608Prospects for a dengue virus vaccine
Q27477646Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis
Q54569367Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study
Q24655655Role of dendritic cells in antibody-dependent enhancement of dengue virus infection
Q33430173SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation
Q34264672Susceptibility and Response of Human Blood Monocyte Subsets to Primary Dengue Virus Infection
Q27488351TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais
Q36978907The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability
Q37904027The pathogenesis of dengue
Q33981109Toll-like receptor 4 polymorphisms in dengue virus-infected children
Q27486917Tumor Necrosis Factor Alpha Protects against Lethal West Nile Virus Infection by Promoting Trafficking of Mononuclear Leukocytes into the Central Nervous System
Q37183637Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients

Search more.